Explore the latest in asthma, including recent guidelines and advances in prevention and treatment of child and adult reactive airway disease.
This narrative review discusses common presenting symptoms, associated otorhinolaryngology symptoms, diagnostic workup, endoscopic features, and treatment of eosinophilic esophagitis for the general otolaryngologist.
This Special Communication, the fifth annual update on medical overuse, discusses 10 studies published in 2017 that are most relevant to understanding medical overuse in adults.
This cohort study uses data from the Premier Inpatient Database to assess outcomes associated with the addition of antibiotic treatment in patients hospitalized for asthma exacerbation treated with corticosteroids who had no other indication for antibiotic therapy.
This systematic review evaluates randomized clinical trials to assess evidence about theory-based behavioral change programs for children and young adults with a chronic illness.
This cohort study assesses the association between asthma, levels of asthma control, and atrial fibrillation in a Norwegian adult population.
This study examines the frequency of steroid use for acute respiratory tract infections in Louisiana and nationally, and factors associated with this clinical practice.
This randomized clinical trial compares the effects of 2 vitamin D dosing strategies on recurrent wheezing in black infants at 12months of age who were born preterm.
This pharmacoepidemiology study uses 1999-2014 NHANES data to characterize trends in use of prescription medications among children and adolescents aged 0 to 19 years in the United States.
This Medical Letter review summarizes the mechanism of action, results from clinical studies, and adverse effects of benralizumab, a humanized monoclonal antibody selective for the interleukin-5 receptor, for add-on maintenance treatment of severe asthma among patients aged 12 years or older with an eosinophilic phenotype .
This JAMA Patient Page describes the medications used to treat asthma.
This systematic review and meta-analysis assesses the effects of long-acting muscarinic antagonist vs placebo or vs other controllers as an add-on therapy to inhaled corticosteroids and the use of triple therapy vs inhaled corticosteroids and long-acting β-agonists in patients with uncontrolled, persistent asthma.
This systematic review and meta-analysis of randomized trials compares the efficacy of combined use of inhaled corticosteroids and long-acting β-agonists (LABAs) as the controller and the quick relief therapy (SMART) vs the same or higher doses of inhaled corticosteroids with or without a LABA used as the controller therapy and short-acting β-agonists as the relief therapy in patients with persistent asthma.
This randomized clinical trial evaluates the effect of the School-Based Telemedicine Enhanced Asthma Management program on asthma morbidity among urban children with persistent asthma.
This case report describes a patient with human herpesvirus 8–associated inflammatory cytokine syndrome.
This nested case-control study investigates the risk of cardiovascular disease associated with long-acting β2-agonists and long-acting antimuscarinic antagonists, focusing on the initiation and duration of both therapies.
This follow-up to a randomized clinical trial evaluates the effect of intervention promoting breastfeeding at the child’s birth on asthma, atopic eczema, and lung function after 16 years.
This population-based, case-control study investigates whether the use of inhaled corticosteroid contributes to bone fractures in children with asthma.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: